-transparent.png){kind=logo}
OBJECTIVE To report our experience with i.v. albumin as a means to prevent ovarian hyperstimulation syndrome (OHSS) in high-risk patients. METHODS Retrospective case-series. METHODS University hospital-based IVF program. METHODS Five women undergoing controlled ovarian stimulation for IVF-Based on previous history and/or E2 measurements and number of ovarian follicles, these patients were considered to be at high risk for developing OHSS. METHODS Intravenous albumin was given at the time of oocyte retrieval. Additional doses were given 12 and 24 hours later. METHODS Development of OHSS. RESULTS Four patients developed OHSS; two of them had the severe form of the syndrome. CONCLUSIONS Severe OHSS may develop in high-risk patients despite the prophylactic administration of i.v. albumin.
N Lewit, and
S Kol, and
N Ronen, and
J Itskovitz-Eldor
February 1999,
Fertility and sterility,
N Lewit, and
S Kol, and
N Ronen, and
J Itskovitz-Eldor
April 1994,
Human reproduction (Oxford, England),
N Lewit, and
S Kol, and
N Ronen, and
J Itskovitz-Eldor
August 1997,
Fertility and sterility,
N Lewit, and
S Kol, and
N Ronen, and
J Itskovitz-Eldor
February 1998,
Fertility and sterility,
N Lewit, and
S Kol, and
N Ronen, and
J Itskovitz-Eldor
May 1998,
Human reproduction (Oxford, England),
N Lewit, and
S Kol, and
N Ronen, and
J Itskovitz-Eldor
July 1999,
Human reproduction (Oxford, England),
N Lewit, and
S Kol, and
N Ronen, and
J Itskovitz-Eldor
April 1995,
Human reproduction (Oxford, England),
N Lewit, and
S Kol, and
N Ronen, and
J Itskovitz-Eldor
November 1994,
Human reproduction (Oxford, England),
N Lewit, and
S Kol, and
N Ronen, and
J Itskovitz-Eldor
October 1995,
Fertility and sterility,
N Lewit, and
S Kol, and
N Ronen, and
J Itskovitz-Eldor
October 1995,
Human reproduction (Oxford, England),
